Cellectis S.A (NASDAQ:CLLS) announces the potential resale of up to 44M shares or American Depositary Shares of Cellectis S.A. by AstraZeneca Holdings B.V. or its transferees. The shares include: 16M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback